Bayer/GSK bravely to bet Levitra in impotence market.

Published: 2004-07-21 06:59:00

Updated: 2004-07-21 06:59:00

In the first year anniversary event of launching Levitra, an anti-impotence drug, Bayer and GSK Korea have placed an aggressive gesture against the anti-impotence drug market under the new imaginative concept of "Hard Levitra"

In a talk meeting at Chosun hotel on July 19, 11 a.m., Bayer and GS...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK